Elmer Schabel, MD
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Elmer Schabel, MD, is working as clinical assessor at the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the drug regulatory authority in Germany. After several years of clinical education he joined BfArM in 1997, where he is responsible for all pre- and post-licensing regulatory activity regarding chemically defined medicinal products in the field of gastroenterology and hepatology.
He became subsequently involved into the European network of regulators centered at the European Medicines Agency (EMA) in London. Since 2005 he has been working with the Scientific Advice Working Party (SAWP), of which he became a full Member in 2008. The SAWP is responsible for advising companies on their pre- and post-licensing drug development plans. In 2010 he was also appointed a member of the Gastroenterology Drafting Group at the EMA, which is in charge of the preparation of Scientific Guidelines in the field of gastroenterology and hepatology.